NIH Chief Varmus, In His Second Year, Credited With Reinvigorating Agency

Questions remain about the low-key director's handling of clinical research, Congress, and scientific misconduct Not yet two years into his tenure as head of the National Institutes of Health, Harold E. Varmus is getting high marks from many scientists for his low-key, but thorough efforts to rejuvenate the agency's biomedical research effort. Initiatives to sharpen the basic science being done on campus and to streamline the peer review of proposals from outside researchers are bringing new

| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share


Questions remain about the low-key director's handling of clinical research, Congress, and scientific misconduct
Not yet two years into his tenure as head of the National Institutes of Health, Harold E. Varmus is getting high marks from many scientists for his low-key, but thorough efforts to rejuvenate the agency's biomedical research effort. Initiatives to sharpen the basic science being done on campus and to streamline the peer review of proposals from outside researchers are bringing new energy to the health agency from top to bottom, they say.

"Varmus has looked at NIH afresh from, I think, every perspective, both intra- and extramurally," says Samuel C. Silverstein, chairman of the physiology and cellular biophysics department at Columbia University College of Physicians and Surgeons and president of the Federation of American Societies for Experimental Biology (FASEB).

Some scientists and others maintain that NIH director Harold E. Varmus has given short shrift to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Franklin Hoke

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours